1. Home
  2. KWR vs VCEL Comparison

KWR vs VCEL Comparison

Compare KWR & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

KWR

Quaker Houghton

HOLD

Current Price

$169.53

Market Cap

2.8B

Sector

Industrials

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$43.84

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KWR
VCEL
Founded
1918
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.4B
IPO Year
1994
1996

Fundamental Metrics

Financial Performance
Metric
KWR
VCEL
Price
$169.53
$43.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$167.00
$57.75
AVG Volume (30 Days)
125.1K
454.1K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
1.52%
N/A
EPS Growth
N/A
60.00
EPS
2.68
N/A
Revenue
$1,888,634,000.00
$276,259,000.00
Revenue This Year
$5.16
$19.40
Revenue Next Year
$3.63
$18.24
P/E Ratio
$63.70
N/A
Revenue Growth
2.66
16.45
52 Week Low
$112.18
$28.95
52 Week High
$183.01
$49.32

Technical Indicators

Market Signals
Indicator
KWR
VCEL
Relative Strength Index (RSI) 60.51 43.93
Support Level $132.58 $32.44
Resistance Level $183.01 $49.04
Average True Range (ATR) 7.00 1.53
MACD 0.39 -0.39
Stochastic Oscillator 80.08 10.37

Price Performance

Historical Comparison
KWR
VCEL

About KWR Quaker Houghton

Quaker Houghton manufactures and sells a variety of industrial process fluids. The company's product portfolio includes metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids, and surface treatment chemicals. The company's geographic segments include the Americas, EMEA, and Asia/Pacific. The majority of the company's revenue is earned from the Americas.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: